Macrogenics Inc. (MGNX) NASDAQ
$14.72 (0.24) (-1.60%)
Market Cap: $933.98M
As of 03/28/24 04:00 PM EDT. Market closed.
Macrogenics Inc. (MGNX)
NASDAQ
$14.72
(0.24) (-1.60%)
Market Cap: $933.98M
As of 03/28/24 04:00 PM EDT. Market closed.
a career at macrogenics could be waiting for you! please click on "careers" ---------------------------->>> to learn more. macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. macrogenics creates both differentiated molecules that are directed to ... read more
a career at macrogenics could be waiting for you! please click on "careers" ---------------------------->>> to learn more. macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. macrogenics creates both differentiated molecules that are directed to novel cancer targets, as well as “bio-betters,” which are drugs designed to improve upon marketed medicines. the combination of macrogenics’ technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. these are exciting times at macrogenics and we hope that you will take the opportunity to learn more about our organization, our pipeline and to view our job opportunities! read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Peters Jeffrey Stuart | Senior VP and General Counsel | Mar 06, 2024 | Option Exercise | $10.90 | 19,625 | 213,875 | 28,520 | Mar 08, 2024, 04:14 PM |
Peters Jeffrey Stuart | Senior VP and General Counsel | Mar 06, 2024 | Sale | $21.50 | 19,625 | 421,938 | 8,895 | Mar 08, 2024, 04:14 PM |
Risser Eric Blasius | Chief Operating Officer | Mar 04, 2024 | Option Exercise | $10.15 | 15,000 | 152,250 | 80,059 | Mar 06, 2024, 04:20 PM |
Risser Eric Blasius | Chief Operating Officer | Mar 04, 2024 | Sale | $19.76 | 41,159 | 813,501 | 65,059 | Mar 06, 2024, 04:20 PM |
Spitznagel Thomas | Sr VP, Technical Ops | Mar 04, 2024 | Option Exercise | $11.50 | 10,000 | 115,000 | 18,316 | Mar 06, 2024, 04:19 PM |
Spitznagel Thomas | Sr VP, Technical Ops | Mar 04, 2024 | Sale | $20.00 | 10,000 | 200,000 | 8,316 | Mar 06, 2024, 04:19 PM |
Karrels James | SVP, CFO and Secretary | Mar 04, 2024 | Sale | $20.50 | 30,000 | 615,000 | 171,452 | Mar 06, 2024, 04:18 PM |
Peters Jeffrey Stuart | Senior VP and General Counsel | Feb 26, 2024 | Sale | $17.22 | 16,124 | 277,655 | 8,895 | Feb 28, 2024, 04:20 PM |
Peters Jeffrey Stuart | Senior VP and General Counsel | Feb 22, 2024 | Option Exercise | $17.11 | 10,126 | 173,256 | 25,019 | Feb 26, 2024, 04:27 PM |
Bonvini Ezio | Sr VP, Research & CSO | Feb 22, 2024 | Option Exercise | $17.11 | 9,366 | 160,252 | 100,892 | Feb 26, 2024, 04:26 PM |
Eck Stephen L. | Chief Medical Officer | Feb 15, 2024 | Option Exercise | $17.40 | 6,872 | 119,573 | 9,798 | Feb 20, 2024, 06:41 PM |
Peters Jeffrey Stuart | Senior VP and General Counsel | Feb 15, 2024 | Option Exercise | $17.40 | 4,441 | 77,273 | 8,895 | Feb 20, 2024, 06:05 PM |
Koenig Scott | President and CEO | Feb 15, 2024 | Option Exercise | $17.40 | 14,349 | 249,673 | 1,077,628 | Feb 20, 2024, 06:04 PM |
Cilinski Lynn | VP, Controller and Treasurer | Feb 15, 2024 | Option Exercise | $17.40 | 2,378 | 41,377 | 6,213 | Feb 20, 2024, 06:04 PM |
Risser Eric Blasius | Chief Operating Officer | Feb 15, 2024 | Option Exercise | $17.40 | 5,879 | 102,295 | 65,059 | Feb 20, 2024, 06:04 PM |
Karrels James | SVP, CFO and Secretary | Feb 15, 2024 | Option Exercise | $17.40 | 5,327 | 92,690 | 201,452 | Feb 20, 2024, 06:04 PM |
Spitznagel Thomas | Sr VP, Technical Ops | Feb 15, 2024 | Option Exercise | $17.40 | 5,020 | 87,348 | 8,316 | Feb 20, 2024, 06:03 PM |
Bonvini Ezio | Sr VP, Research & CSO | Feb 15, 2024 | Option Exercise | $17.40 | 5,871 | 102,155 | 82,133 | Feb 20, 2024, 06:03 PM |
Bonvini Ezio | Sr VP, Research & CSO | Feb 07, 2024 | Sale | $18.00 | 3,334 | 60,012 | 71,334 | Feb 07, 2024, 04:19 PM |
Peters Jeffrey Stuart | Senior VP and General Counsel | Feb 05, 2024 | Option Exercise | $11.11 | 76,251 | 847,355 | 76,251 | Feb 07, 2024, 04:17 PM |
Peters Jeffrey Stuart | Senior VP and General Counsel | Feb 05, 2024 | Sale | $16.50 | 76,251 | 1,258,142 | 21,875 | Feb 07, 2024, 04:17 PM |
Bonvini Ezio | Sr VP, Research & CSO | Feb 01, 2024 | Sale | $15.00 | 13,316 | 199,740 | 74,668 | Feb 02, 2024, 04:21 PM |
Bonvini Ezio | Sr VP, Research & CSO | Jan 19, 2024 | Sale | $12.00 | 13,316 | 159,792 | 87,984 | Jan 22, 2024, 04:57 PM |
Bonvini Ezio | Sr VP, Research & CSO | Dec 20, 2023 | Sale | $10.08 | 18,880 | 190,310 | 101,300 | Dec 21, 2023, 04:12 PM |
BIOTECH TARGET N V | 10% Owner | Oct 02, 2023 | Buy | $4.46 | 150,000 | 669,585 | 9,929,963 | Oct 04, 2023, 03:31 PM |
BIOTECH TARGET N V | 10% Owner | Sep 07, 2023 | Buy | $5.26 | 200,000 | 1,052,840 | 9,779,963 | Sep 11, 2023, 03:39 PM |
HURWITZ EDWARD | Director | Aug 30, 2023 | Buy | $4.91 | 15,000 | 73,650 | 33,074 | Sep 01, 2023, 04:06 PM |
Peters Jeffrey Stuart | Senior VP and General Counsel | Mar 10, 2023 | Sale | $6.03 | 5,372 | 32,393 | 0 | Mar 14, 2023, 04:22 PM |
Peters Jeffrey Stuart | Senior VP and General Counsel | Feb 22, 2023 | Option Exercise | $6.55 | 3,378 | 22,126 | 5,372 | Feb 24, 2023, 04:35 PM |
Bonvini Ezio | Sr VP, Research & CSO | Feb 22, 2023 | Option Exercise | $6.55 | 3,619 | 23,704 | 120,180 | Feb 24, 2023, 04:34 PM |
BIOTECH TARGET N V | 10% Owner | Feb 14, 2023 | Buy | $5.07 | 500,000 | 2,532,600 | 9,579,963 | Feb 16, 2023, 12:37 PM |
BIOTECH TARGET N V | 10% Owner | Jan 19, 2023 | Buy | $5.30 | 150,000 | 794,925 | 9,079,963 | Jan 23, 2023, 04:21 PM |
BIOTECH TARGET N V | 10% Owner | Dec 27, 2022 | Buy | $5.61 | 200,000 | 1,121,800 | 8,929,963 | Dec 28, 2022, 11:03 AM |
BIOTECH TARGET N V | 10% Owner | Dec 23, 2022 | Buy | $5.88 | 200,000 | 1,176,800 | 8,729,963 | Dec 28, 2022, 11:03 AM |
BIOTECH TARGET N V | 10% Owner | Nov 22, 2022 | Buy | $5.96 | 300,000 | 1,788,180 | 8,529,963 | Nov 25, 2022, 11:37 AM |
Risser Eric Blasius | Chief Operating Officer | Oct 28, 2022 | Option Exercise | $1.51 | 8,500 | 12,835 | 53,468 | Oct 31, 2022, 04:36 PM |
BIOTECH TARGET N V | 10% Owner | Oct 21, 2022 | Buy | $4.63 | 250,000 | 1,157,100 | 7,979,963 | Oct 25, 2022, 04:19 PM |
BIOTECH TARGET N V | 10% Owner | Oct 24, 2022 | Buy | $4.36 | 250,000 | 1,090,500 | 8,229,963 | Oct 25, 2022, 04:19 PM |
BIOTECH TARGET N V | 10% Owner | Oct 20, 2022 | Buy | $4.00 | 285,977 | 1,143,565 | 7,729,963 | Oct 21, 2022, 03:03 PM |
BIOTECH TARGET N V | 10% Owner | Oct 19, 2022 | Buy | $3.70 | 168,422 | 623,919 | 7,443,986 | Oct 21, 2022, 03:03 PM |
Karrels James | SVP, CFO and Secretary | Jun 15, 2022 | Buy | $2.47 | 40,000 | 98,800 | 191,776 | Jun 17, 2022, 04:18 PM |
Bonvini Ezio | Sr VP, Research & CSO | May 14, 2022 | Option Exercise | $4.16 | 1,666 | 6,931 | 114,424 | May 17, 2022, 05:28 PM |
Koenig Scott | President and CEO | May 16, 2022 | Option Exercise | $1.51 | 53,265 | 80,430 | 1,049,636 | May 17, 2022, 05:20 PM |
Karrels James | SVP, CFO and Secretary | Mar 28, 2022 | Option Exercise | $1.51 | 8,316 | 12,557 | 151,776 | Mar 28, 2022, 04:56 PM |
Risser Eric Blasius | Chief Operating Officer | Mar 04, 2022 | Option Exercise | $0.94 | 500 | 470 | 44,968 | Mar 04, 2022, 05:45 PM |
BIOTECH TARGET N V | 10% Owner | Nov 19, 2021 | Buy | $18.50 | 200,000 | 3,700,320 | 7,275,564 | Nov 23, 2021, 12:29 PM |
Bonvini Ezio | Sr VP, Research & CSO | Nov 16, 2021 | Option Exercise | $16.00 | 2,540 | 40,640 | 111,090 | Nov 16, 2021, 05:30 PM |
BIOTECH TARGET N V | 10% Owner | Sep 29, 2021 | Buy | $20.47 | 100,000 | 2,047,460 | 7,075,564 | Sep 30, 2021, 03:09 PM |
BIOTECH TARGET N V | 10% Owner | Sep 28, 2021 | Buy | $20.64 | 100,000 | 2,063,960 | 6,975,564 | Sep 30, 2021, 03:09 PM |
BIOTECH TARGET N V | 10% Owner | Sep 16, 2021 | Buy | $20.94 | 400,000 | 8,376,800 | 6,675,564 | Sep 20, 2021, 12:21 PM |
BIOTECH TARGET N V | 10% Owner | Sep 17, 2021 | Buy | $19.93 | 200,000 | 3,986,680 | 6,875,564 | Sep 20, 2021, 12:21 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | Jul 16, 2021 | Option Exercise | $7.51 | 5,000 | 37,550 | 5,000 | Jul 20, 2021, 05:09 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | Jul 16, 2021 | Sale | $25.01 | 5,000 | 125,050 | 0 | Jul 20, 2021, 05:09 PM |
Bonvini Ezio | Sr VP, Research & CSO | Jun 24, 2021 | Option Exercise | $16.73 | 26,076 | 436,337 | 108,550 | Jun 28, 2021, 08:14 PM |
BIOTECH TARGET N V | 10% Owner | Jun 21, 2021 | Buy | $21.74 | 75,000 | 1,630,170 | 6,275,564 | Jun 23, 2021, 01:33 PM |
BIOTECH TARGET N V | 10% Owner | Jun 15, 2021 | Buy | $20.53 | 75,000 | 1,539,615 | 6,100,564 | Jun 17, 2021, 02:54 PM |
BIOTECH TARGET N V | 10% Owner | Jun 16, 2021 | Buy | $21.04 | 100,000 | 2,104,390 | 6,200,564 | Jun 17, 2021, 02:54 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | Apr 15, 2021 | Option Exercise | $7.51 | 5,000 | 37,550 | 5,000 | Apr 19, 2021, 06:37 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | Apr 15, 2021 | Sale | $30.91 | 5,000 | 154,550 | 0 | Apr 19, 2021, 06:37 PM |
Karrels James | SVP, CFO and Secretary | Mar 22, 2021 | Sale | $33.00 | 15,000 | 495,000 | 143,460 | Mar 24, 2021, 05:07 PM |
Bonvini Ezio | Sr VP, Research & CSO | Mar 22, 2021 | Sale | $32.00 | 3,917 | 125,344 | 79,890 | Mar 24, 2021, 05:04 PM |
Peters Jeffrey Stuart | General Counsel | Mar 08, 2021 | Option Exercise | $11.50 | 21,749 | 250,114 | 21,749 | Mar 09, 2021, 07:55 PM |
Peters Jeffrey Stuart | General Counsel | Mar 08, 2021 | Sale | $26.50 | 21,749 | 576,349 | 0 | Mar 09, 2021, 07:55 PM |
Karrels James | SVP, CFO and Secretary | Jan 28, 2021 | Option Exercise | $1.41 | 6,000 | 8,490 | 158,460 | Jan 29, 2021, 05:10 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Dec 29, 2020 | Option Exercise | $1.51 | 500 | 755 | 44,968 | Dec 30, 2020, 04:05 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Dec 29, 2020 | Sale | $24.10 | 500 | 12,050 | 44,468 | Dec 30, 2020, 04:05 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Nov 30, 2020 | Option Exercise | $1.51 | 500 | 755 | 44,968 | Dec 01, 2020, 04:15 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Nov 30, 2020 | Sale | $23.35 | 500 | 11,675 | 44,468 | Dec 01, 2020, 04:15 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Oct 28, 2020 | Option Exercise | $1.51 | 1,500 | 2,265 | 45,968 | Oct 29, 2020, 07:52 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Oct 28, 2020 | Sale | $20.69 | 1,500 | 31,035 | 44,468 | Oct 29, 2020, 07:52 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Sep 28, 2020 | Option Exercise | $1.51 | 500 | 755 | 44,968 | Sep 29, 2020, 04:44 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Sep 28, 2020 | Sale | $25.33 | 500 | 12,665 | 44,468 | Sep 29, 2020, 04:44 PM |
Bonvini Ezio | Sr VP, Research & CSO | Sep 18, 2020 | Sale | $32.00 | 18,339 | 586,848 | 83,807 | Sep 21, 2020, 04:51 PM |
Bonvini Ezio | Sr VP, Research & CSO | Sep 17, 2020 | Sale | $29.88 | 44,512 | 1,330,019 | 102,146 | Sep 21, 2020, 04:51 PM |
Galbraith Kenneth | Director | Sep 09, 2020 | Option Exercise | $17.38 | 20,773 | 361,103 | 13,849 | Sep 10, 2020, 04:44 PM |
Galbraith Kenneth | Director | Sep 09, 2020 | Sale | $27.11 | 20,773 | 563,156 | 0 | Sep 10, 2020, 04:44 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Aug 26, 2020 | Option Exercise | $1.51 | 500 | 755 | 44,968 | Aug 27, 2020, 05:04 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Aug 26, 2020 | Sale | $27.10 | 500 | 13,550 | 44,468 | Aug 27, 2020, 05:04 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | Aug 20, 2020 | Option Exercise | $7.51 | 7,500 | 56,325 | 7,500 | Aug 21, 2020, 04:05 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | Aug 20, 2020 | Sale | $26.87 | 7,500 | 201,525 | 0 | Aug 21, 2020, 04:05 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jul 27, 2020 | Option Exercise | $1.45 | 4,489 | 6,500 | 48,468 | Jul 28, 2020, 05:12 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jul 27, 2020 | Sale | $25.47 | 4,489 | 114,319 | 47,468 | Jul 28, 2020, 05:12 PM |
Peters Jeffrey Stuart | General Counsel | Jul 02, 2020 | Sale | $30.00 | 202 | 6,060 | 0 | Jul 06, 2020, 04:25 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jul 02, 2020 | Option Exercise | $1.51 | 3,100 | 4,681 | 47,568 | Jul 06, 2020, 04:25 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jul 02, 2020 | Sale | $30.00 | 3,100 | 93,000 | 44,468 | Jul 06, 2020, 04:25 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jun 24, 2020 | Option Exercise | $0.94 | 500 | 470 | 44,968 | Jun 25, 2020, 04:57 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jun 24, 2020 | Sale | $28.49 | 500 | 14,245 | 44,468 | Jun 25, 2020, 04:57 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | May 26, 2020 | Option Exercise | $0.94 | 500 | 470 | 44,968 | May 27, 2020, 04:43 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | May 26, 2020 | Sale | $26.59 | 500 | 13,295 | 44,468 | May 27, 2020, 04:43 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | May 20, 2020 | Option Exercise | $7.51 | 7,500 | 56,325 | 7,500 | May 21, 2020, 07:44 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | May 20, 2020 | Sale | $25.30 | 7,500 | 189,750 | 0 | May 21, 2020, 07:44 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | May 06, 2020 | Option Exercise | $1.47 | 8,032 | 11,843 | 52,500 | May 07, 2020, 04:22 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | May 06, 2020 | Sale | $20.95 | 8,032 | 168,300 | 52,000 | May 07, 2020, 04:22 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Apr 16, 2020 | Option Exercise | $0.94 | 6,000 | 5,640 | 44,468 | Apr 17, 2020, 04:11 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Mar 13, 2020 | Option Exercise | $0.94 | 6,000 | 5,640 | 38,468 | Mar 17, 2020, 04:09 PM |
Koenig Scott | President and CEO | Mar 11, 2020 | Option Exercise | $0.94 | 133,163 | 125,173 | 943,103 | Mar 13, 2020, 04:15 PM |
Karrels James | SVP, CFO and Secretary | Mar 06, 2020 | Option Exercise | $0.94 | 4,473 | 4,205 | 152,460 | Mar 09, 2020, 04:39 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 20, 2020 | Option Exercise | $0.94 | 500 | 470 | 32,968 | Feb 21, 2020, 04:44 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 20, 2020 | Sale | $10.84 | 500 | 5,420 | 32,468 | Feb 21, 2020, 04:44 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 04, 2020 | Option Exercise | $0.94 | 30 | 28 | 32,498 | Feb 06, 2020, 04:41 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 05, 2020 | Option Exercise | $0.94 | 623 | 586 | 33,091 | Feb 06, 2020, 04:41 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 05, 2020 | Sale | $10.00 | 623 | 6,230 | 32,468 | Feb 06, 2020, 04:41 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 04, 2020 | Sale | $10.00 | 30 | 300 | 32,468 | Feb 06, 2020, 04:41 PM |
Karrels James | SVP, CFO and Secretary | Jan 30, 2020 | Option Exercise | $0.94 | 12,500 | 11,750 | 147,987 | Jan 31, 2020, 04:45 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Sep 27, 2019 | Option Exercise | $0.94 | 1,662 | 1,562 | 32,468 | Oct 03, 2019, 04:33 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | May 20, 2019 | Option Exercise | $0.94 | 3,000 | 2,820 | 33,806 | May 22, 2019, 04:21 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | May 22, 2019 | Option Exercise | $0.94 | 1,000 | 940 | 31,806 | May 22, 2019, 04:21 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | May 22, 2019 | Sale | $19.03 | 1,000 | 19,026 | 30,806 | May 22, 2019, 04:21 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | May 20, 2019 | Sale | $18.38 | 3,000 | 55,131 | 30,806 | May 22, 2019, 04:21 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Mar 14, 2019 | Option Exercise | $0.94 | 2,497 | 2,347 | 30,806 | Mar 18, 2019, 04:36 PM |
Fust Matthew K | Director | Feb 06, 2019 | Option Exercise | $20.15 | 6,924 | 139,519 | 7,424 | Feb 08, 2019, 05:41 PM |
Fust Matthew K | Director | Feb 06, 2019 | Sale | $29.38 | 6,924 | 203,427 | 500 | Feb 08, 2019, 05:41 PM |
Peters Jeffrey Stuart | General Counsel | Feb 06, 2019 | Sale | $30.00 | 68 | 2,040 | 202 | Feb 08, 2019, 05:40 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | Feb 06, 2019 | Option Exercise | $7.51 | 1,770 | 13,293 | 1,770 | Feb 08, 2019, 05:40 PM |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | Feb 06, 2019 | Sale | $30.00 | 1,770 | 53,100 | 0 | Feb 08, 2019, 05:40 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jan 28, 2019 | Option Exercise | $0.94 | 6,000 | 5,640 | 28,309 | Jan 28, 2019, 04:12 PM |
Karrels James | SVP, CFO and Secretary | Jan 24, 2019 | Option Exercise | $0.94 | 7,326 | 6,886 | 135,487 | Jan 28, 2019, 04:10 PM |
Karrels James | SVP, CFO and Secretary | Jan 08, 2019 | Option Exercise | $0.94 | 5,314 | 4,995 | 128,161 | Jan 10, 2019, 03:58 PM |
Koenig Scott | President and CEO | Jan 03, 2019 | Option Exercise | $0.94 | 39,897 | 37,503 | 213,060 | Jan 04, 2019, 04:29 PM |
Karrels James | SVP, CFO and Secretary | Dec 18, 2018 | Option Exercise | $0.94 | 5,000 | 4,700 | 122,847 | Dec 20, 2018, 04:04 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Dec 12, 2018 | Option Exercise | $0.94 | 5,000 | 4,700 | 22,309 | Dec 13, 2018, 04:39 PM |
Karrels James | SVP, CFO and Secretary | Nov 27, 2018 | Option Exercise | $0.94 | 3,000 | 2,820 | 117,847 | Nov 27, 2018, 04:44 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Nov 13, 2018 | Option Exercise | $0.94 | 4,000 | 3,760 | 16,100 | Nov 14, 2018, 04:48 PM |
Koenig Scott | President and CEO | Nov 13, 2018 | Option Exercise | $0.94 | 40,000 | 37,600 | 173,163 | Nov 14, 2018, 04:32 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Oct 22, 2018 | Option Exercise | $0.94 | 3,000 | 2,820 | 12,100 | Oct 23, 2018, 12:32 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Mar 12, 2018 | Option Exercise | $0.94 | 1,000 | 940 | 10,100 | Mar 14, 2018, 05:12 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Mar 12, 2018 | Sale | $31.08 | 1,000 | 31,080 | 9,100 | Mar 14, 2018, 05:12 PM |
Karrels James | SVP, CFO and Secretary | Mar 05, 2018 | Sale | $31.00 | 5,000 | 155,000 | 114,847 | Mar 07, 2018, 06:46 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Mar 02, 2018 | Option Exercise | $0.94 | 4,000 | 3,760 | 13,100 | Mar 06, 2018, 05:24 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Mar 02, 2018 | Sale | $30.00 | 4,000 | 120,000 | 9,100 | Mar 06, 2018, 05:24 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 28, 2018 | Option Exercise | $0.94 | 1,000 | 940 | 10,100 | Mar 01, 2018, 05:24 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 28, 2018 | Sale | $25.00 | 1,000 | 25,005 | 9,100 | Mar 01, 2018, 05:24 PM |
Cilinski Lynn | VP, Controller and Treasurer | Feb 28, 2018 | Option Exercise | $1.13 | 23,967 | 27,083 | 25,890 | Mar 01, 2018, 05:24 PM |
Cilinski Lynn | VP, Controller and Treasurer | Feb 28, 2018 | Sale | $25.01 | 23,967 | 599,436 | 1,923 | Mar 01, 2018, 05:24 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Feb 26, 2018 | Option Exercise | $23.46 | 11,070 | 259,702 | 18,930 | Feb 27, 2018, 05:49 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jan 24, 2018 | Option Exercise | $0.94 | 3,000 | 2,820 | 12,100 | Jan 26, 2018, 04:01 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jan 24, 2018 | Sale | $22.50 | 3,000 | 67,500 | 9,100 | Jan 26, 2018, 04:01 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jan 24, 2018 | Option Exercise | $0.94 | 3,000 | 2,820 | 12,100 | Jan 25, 2018, 05:22 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jan 24, 2018 | Sale | $22.50 | 3,000 | 67,500 | 9,100 | Jan 25, 2018, 05:22 PM |
Karrels James | SVP, CFO and Secretary | Jan 16, 2018 | Option Exercise | $0.94 | 6,516 | 6,125 | 119,847 | Jan 18, 2018, 05:19 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Jan 17, 2018 | Option Exercise | $4.70 | 2,524 | 11,863 | 32,524 | Jan 18, 2018, 05:19 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Jan 16, 2018 | Option Exercise | $4.70 | 2,476 | 11,637 | 32,476 | Jan 18, 2018, 05:19 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Jan 17, 2018 | Sale | $20.00 | 2,524 | 50,480 | 30,000 | Jan 18, 2018, 05:19 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Jan 16, 2018 | Sale | $20.00 | 2,476 | 49,520 | 30,000 | Jan 18, 2018, 05:19 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Jan 17, 2018 | Option Exercise | $0.94 | 2,000 | 1,880 | 9,100 | Jan 18, 2018, 05:19 PM |
Karrels James | SVP, CFO and Secretary | Dec 29, 2017 | Option Exercise | $0.94 | 3,000 | 2,820 | 113,331 | Jan 03, 2018, 12:00 AM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Nov 21, 2017 | Option Exercise | $4.70 | 5,000 | 23,500 | 35,000 | Nov 21, 2017, 05:15 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Nov 21, 2017 | Sale | $20.00 | 5,000 | 100,000 | 30,000 | Nov 21, 2017, 05:15 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Oct 25, 2017 | Option Exercise | $4.70 | 10,000 | 47,000 | 40,000 | Oct 26, 2017, 09:37 AM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Oct 25, 2017 | Sale | $20.00 | 10,000 | 200,000 | 30,000 | Oct 26, 2017, 09:37 AM |
Karrels James | SVP, CFO and Secretary | Sep 05, 2017 | Option Exercise | $0.94 | 5,000 | 4,700 | 110,331 | Sep 07, 2017, 04:54 PM |
Risser Eric Blasius | Sr VP & Chief Business Officer | Sep 05, 2017 | Option Exercise | $0.94 | 2,000 | 1,880 | 6,000 | Sep 07, 2017, 04:52 PM |
Bonvini Ezio | Sr VP, Research & CSO | Jul 26, 2017 | Option Exercise | $1.22 | 53,264 | 65,248 | 146,658 | Jul 27, 2017, 04:47 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Jun 05, 2017 | Option Exercise | $4.70 | 5,000 | 23,500 | 35,000 | Jun 06, 2017, 04:04 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Jun 05, 2017 | Sale | $20.00 | 5,000 | 100,000 | 30,000 | Jun 06, 2017, 04:04 PM |
SARAN ATUL | SVP & General Counsel | Apr 28, 2017 | Option Exercise | $21.61 | 1,862 | 40,238 | 16,986 | May 02, 2017, 12:58 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Apr 19, 2017 | Option Exercise | $4.70 | 15,000 | 70,500 | 45,000 | Apr 20, 2017, 04:15 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Apr 19, 2017 | Sale | $20.00 | 15,000 | 300,000 | 30,000 | Apr 20, 2017, 04:15 PM |
Karrels James | SVP, CFO and Secretary | Jan 25, 2017 | Option Exercise | $0.94 | 5,000 | 4,700 | 105,331 | Jan 26, 2017, 04:36 PM |
Koenig Scott | President and CEO | Jan 17, 2017 | Option Exercise | $0.94 | 79,898 | 75,104 | 133,163 | Jan 19, 2017, 04:40 PM |
Bonvini Ezio | Sr VP, Research & CSO | Oct 19, 2016 | Option Exercise | $0.94 | 5,349 | 5,028 | 100,944 | Oct 21, 2016, 07:19 PM |
Bonvini Ezio | Sr VP, Research & CSO | Feb 11, 2016 | Option Exercise | $0.94 | 11,962 | 11,244 | 95,595 | Oct 21, 2016, 07:19 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Oct 03, 2016 | Option Exercise | $4.70 | 10,000 | 47,000 | 10,000 | Oct 19, 2016, 05:20 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Oct 03, 2016 | Sale | $29.34 | 10,000 | 293,400 | 0 | Oct 19, 2016, 05:20 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Oct 03, 2016 | Option Exercise | $4.70 | 10,000 | 47,000 | 10,000 | Oct 05, 2016, 04:49 PM |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Oct 03, 2016 | Sale | $29.34 | 10,000 | 293,400 | 0 | Oct 05, 2016, 04:49 PM |
Cilinski Lynn | VP, Controller and Treasurer | Oct 03, 2016 | Option Exercise | $0.94 | 6,231 | 5,857 | 8,154 | Oct 05, 2016, 04:49 PM |
Cilinski Lynn | VP, Controller and Treasurer | Oct 03, 2016 | Sale | $29.28 | 6,231 | 182,444 | 1,923 | Oct 05, 2016, 04:49 PM |
Wigginton Jon Marc | Sr VP Clinical Dev & CMO | Aug 01, 2016 | Option Exercise | $4.70 | 20,000 | 94,000 | 20,000 | Aug 03, 2016, 04:51 PM |
Wigginton Jon Marc | Sr VP Clinical Dev & CMO | Aug 01, 2016 | Sale | $30.78 | 20,000 | 615,600 | 0 | Aug 03, 2016, 04:51 PM |
Wigginton Jon Marc | Sr VP Clinical Dev & CMO | Jul 01, 2016 | Option Exercise | $4.70 | 5,000 | 23,500 | 5,000 | Jul 06, 2016, 08:44 PM |
Wigginton Jon Marc | Sr VP Clinical Dev & CMO | Jul 01, 2016 | Sale | $27.22 | 5,000 | 136,100 | 0 | Jul 06, 2016, 08:44 PM |
Cilinski Lynn | VP, Controller and Treasurer | Jul 01, 2016 | Option Exercise | $0.94 | 8,922 | 8,387 | 10,845 | Jul 06, 2016, 08:43 PM |
Cilinski Lynn | VP, Controller and Treasurer | Jul 01, 2016 | Sale | $27.22 | 8,922 | 242,857 | 1,923 | Jul 06, 2016, 08:43 PM |
SARAN ATUL | SVP & General Counsel | Apr 28, 2016 | Option Exercise | $20.84 | 1,862 | 38,804 | 18,848 | Jun 01, 2016, 11:01 AM |
Cilinski Lynn | VP, Controller and Treasurer | May 27, 2016 | Option Exercise | $0.94 | 5,000 | 4,700 | 6,923 | May 27, 2016, 02:32 PM |
Cilinski Lynn | VP, Controller and Treasurer | May 27, 2016 | Sale | $25.00 | 5,000 | 125,000 | 1,923 | May 27, 2016, 02:32 PM |
Koenig Scott | President and CEO | May 16, 2016 | Option Exercise | $0.94 | 34,619 | 32,542 | 167,782 | May 17, 2016, 11:55 AM |
Koenig Scott | President and CEO | May 11, 2016 | Option Exercise | $0.94 | 79,898 | 75,104 | 133,163 | May 13, 2016, 10:25 AM |
SARAN ATUL | SVP & General Counsel | Apr 28, 2016 | Option Exercise | $20.84 | 1,730 | 36,053 | 18,980 | Apr 29, 2016, 03:38 PM |
Costa Paulo F | Director | Mar 03, 2016 | Buy | $17.20 | 10,000 | 172,000 | 59,435 | Mar 04, 2016, 08:12 AM |
Risser Eric Blasius | SVP, Business Development | Feb 08, 2016 | Option Exercise | $0.94 | 2,500 | 2,350 | 4,000 | Feb 10, 2016, 08:51 PM |
Karrels James | SVP, CFO and Secretary | Jan 29, 2016 | Option Exercise | $0.94 | 10,000 | 9,400 | 100,331 | Feb 02, 2016, 04:42 PM |
Stein Kathryn E | SVP, Product Dev. & Regulatory | Jan 07, 2016 | Option Exercise | $0.86 | 52,350 | 44,825 | 95,555 | Jan 11, 2016, 01:39 PM |
Bonvini Ezio | Senior VP, Research | Jan 07, 2016 | Option Exercise | $0.94 | 13,316 | 12,517 | 83,633 | Jan 11, 2016, 01:39 PM |
Wigginton Jon Marc | Sr VP, Clinical | Jan 04, 2016 | Option Exercise | $4.70 | 10,000 | 47,000 | 10,000 | Jan 06, 2016, 06:51 PM |
Wigginton Jon Marc | Sr VP, Clinical | Jan 04, 2016 | Sale | $29.64 | 10,000 | 296,400 | 0 | Jan 06, 2016, 06:51 PM |
Risser Eric Blasius | SVP, Business Development | Dec 23, 2015 | Option Exercise | $0.94 | 1,500 | 1,410 | 1,500 | Dec 23, 2015, 01:26 PM |
Cilinski Lynn | VP, Controller and Treasurer | Jul 01, 2015 | Option Exercise | $0.94 | 3,815 | 3,586 | 7,659 | Nov 24, 2015, 03:32 PM |
Cilinski Lynn | VP, Controller and Treasurer | Nov 23, 2015 | Option Exercise | $0.94 | 1,185 | 1,114 | 5,029 | Nov 24, 2015, 03:32 PM |
Cilinski Lynn | VP, Controller and Treasurer | Nov 23, 2015 | Sale | $35.00 | 6,921 | 242,235 | 3,844 | Nov 24, 2015, 03:32 PM |
Bonvini Ezio | Senior VP, Research | Nov 16, 2015 | Sale | $31.44 | 3,117 | 97,998 | 70,317 | Nov 17, 2015, 03:22 PM |
Bonvini Ezio | Senior VP, Research | Oct 15, 2015 | Sale | $25.21 | 6,233 | 157,134 | 73,434 | Oct 19, 2015, 03:01 PM |
Bonvini Ezio | Senior VP, Research | Oct 13, 2015 | Option Exercise | $13.12 | 29,042 | 381,031 | 94,188 | Oct 15, 2015, 02:37 PM |
Karrels James | SVP, CFO and Secretary | Oct 07, 2015 | Option Exercise | $0.94 | 6,000 | 5,640 | 10,100 | Oct 09, 2015, 09:52 AM |
Wigginton Jon Marc | Sr VP, Clinical | Oct 01, 2015 | Option Exercise | $4.70 | 5,000 | 23,500 | 5,000 | Oct 07, 2015, 04:08 PM |
Wigginton Jon Marc | Sr VP, Clinical | Oct 01, 2015 | Sale | $21.11 | 5,000 | 105,550 | 0 | Oct 07, 2015, 04:08 PM |
Wigginton Jon Marc | Sr VP, Clinical | Aug 03, 2015 | Option Exercise | $4.70 | 10,000 | 47,000 | 10,000 | Oct 07, 2015, 04:07 PM |
Wigginton Jon Marc | Sr VP, Clinical | Aug 03, 2015 | Sale | $37.15 | 10,000 | 371,500 | 0 | Oct 07, 2015, 04:07 PM |
Bonvini Ezio | Senior VP, Research | Oct 02, 2015 | Option Exercise | $0.94 | 17,877 | 16,804 | 79,667 | Oct 06, 2015, 02:19 PM |
Wigginton Jon Marc | Sr VP, Clinical | Oct 01, 2015 | Option Exercise | $4.70 | 5,000 | 23,500 | 5,000 | Oct 02, 2015, 04:22 PM |
Wigginton Jon Marc | Sr VP, Clinical | Oct 01, 2015 | Sale | $21.11 | 5,000 | 105,550 | 0 | Oct 02, 2015, 04:22 PM |
Bonvini Ezio | Senior VP, Research | Sep 18, 2015 | Option Exercise | $0.94 | 7,000 | 6,580 | 61,790 | Sep 22, 2015, 03:19 PM |
Bonvini Ezio | Senior VP, Research | Sep 16, 2015 | Option Exercise | $0.94 | 4,000 | 3,760 | 54,790 | Sep 18, 2015, 10:33 AM |
Bonvini Ezio | Senior VP, Research | Aug 27, 2015 | Option Exercise | $0.94 | 5,000 | 4,700 | 50,790 | Aug 28, 2015, 11:30 AM |
Bonvini Ezio | Senior VP, Research | Aug 26, 2015 | Option Exercise | $0.94 | 5,000 | 4,700 | 45,790 | Aug 28, 2015, 11:30 AM |
Bonvini Ezio | Senior VP, Research | Aug 10, 2015 | Option Exercise | $0.94 | 80,000 | 75,200 | 40,790 | Aug 11, 2015, 08:41 AM |
Wigginton Jon Marc | Sr VP, Clinical | Aug 03, 2015 | Option Exercise | $4.70 | 10,000 | 47,000 | 10,000 | Aug 03, 2015, 02:47 PM |
Wigginton Jon Marc | Sr VP, Clinical | Aug 03, 2015 | Sale | $37.15 | 10,000 | 371,500 | 0 | Aug 03, 2015, 02:47 PM |
Bonvini Ezio | Senior VP, Research | Jul 10, 2015 | Option Exercise | $0.71 | 2,400 | 1,704 | 39,190 | Jul 13, 2015, 03:23 PM |
Bonvini Ezio | Senior VP, Research | Jul 10, 2015 | Sale | $38.09 | 2,400 | 91,416 | 36,790 | Jul 13, 2015, 03:23 PM |
Cilinski Lynn | VP, Controller and Treasurer | Jul 01, 2015 | Option Exercise | $0.94 | 5,000 | 4,700 | 10,765 | Jul 01, 2015, 04:28 PM |
Cilinski Lynn | VP, Controller and Treasurer | Jul 01, 2015 | Sale | $37.15 | 6,921 | 257,115 | 5,765 | Jul 01, 2015, 04:28 PM |
Wigginton Jon Marc | Sr VP, Clinical | Jul 01, 2015 | Option Exercise | $4.70 | 5,000 | 23,500 | 5,000 | Jul 01, 2015, 04:28 PM |
Wigginton Jon Marc | Sr VP, Clinical | Jul 01, 2015 | Sale | $37.15 | 5,000 | 185,750 | 0 | Jul 01, 2015, 04:28 PM |
Bonvini Ezio | Senior VP, Research | Jun 30, 2015 | Option Exercise | $0.71 | 6,497 | 4,613 | 43,287 | Jul 01, 2015, 04:27 PM |
Bonvini Ezio | Senior VP, Research | Jun 30, 2015 | Sale | $38.07 | 6,497 | 247,341 | 36,790 | Jul 01, 2015, 04:27 PM |
Bonvini Ezio | Senior VP, Research | Jun 24, 2015 | Option Exercise | $0.71 | 6,097 | 4,329 | 42,887 | Jul 01, 2015, 04:27 PM |
Bonvini Ezio | Senior VP, Research | Jun 24, 2015 | Sale | $38.08 | 6,097 | 232,174 | 36,790 | Jul 01, 2015, 04:27 PM |
Bonvini Ezio | Senior VP, Research | Jun 23, 2015 | Option Exercise | $0.71 | 13,054 | 9,268 | 49,844 | Jul 01, 2015, 04:27 PM |
Bonvini Ezio | Senior VP, Research | Jun 23, 2015 | Sale | $38.14 | 13,054 | 497,880 | 36,790 | Jul 01, 2015, 04:27 PM |
Bonvini Ezio | Senior VP, Research | Jun 24, 2015 | Sale | $38.08 | 6,097 | 232,174 | 17,639 | Jun 25, 2015, 03:39 PM |
Bonvini Ezio | Senior VP, Research | Jun 23, 2015 | Sale | $38.14 | 13,054 | 497,880 | 23,736 | Jun 24, 2015, 03:07 PM |
Cilinski Lynn | VP, Controller and Treasurer | Jun 15, 2015 | Option Exercise | $0.94 | 5,000 | 4,700 | 16,465 | Jun 16, 2015, 01:28 PM |
Cilinski Lynn | VP, Controller and Treasurer | Jun 15, 2015 | Sale | $35.00 | 10,700 | 374,500 | 11,465 | Jun 16, 2015, 01:28 PM |
Bonvini Ezio | Senior VP, Research | Jun 15, 2015 | Option Exercise | $0.71 | 6,233 | 4,425 | 43,023 | Jun 16, 2015, 01:28 PM |
Bonvini Ezio | Senior VP, Research | Jun 15, 2015 | Sale | $34.01 | 6,233 | 211,984 | 36,790 | Jun 16, 2015, 01:28 PM |
Bonvini Ezio | Senior VP, Research | May 15, 2015 | Option Exercise | $0.71 | 6,233 | 4,425 | 43,023 | May 18, 2015, 04:15 PM |
Bonvini Ezio | Senior VP, Research | May 15, 2015 | Sale | $30.24 | 6,233 | 188,486 | 36,790 | May 18, 2015, 04:15 PM |
SARAN ATUL | General Counsel | Apr 28, 2015 | Option Exercise | $32.02 | 925 | 29,619 | 20,710 | Apr 29, 2015, 02:32 PM |
Bonvini Ezio | Senior VP, Research | Apr 15, 2015 | Option Exercise | $0.71 | 6,233 | 4,425 | 43,023 | Apr 16, 2015, 11:12 AM |
Bonvini Ezio | Senior VP, Research | Apr 15, 2015 | Sale | $33.98 | 6,233 | 211,797 | 36,790 | Apr 16, 2015, 11:12 AM |
Wigginton Jon Marc | Sr VP, Clinical | Apr 01, 2014 | Option Exercise | $4.70 | 5,000 | 23,500 | 5,000 | Apr 03, 2015, 07:57 AM |
Wigginton Jon Marc | Sr VP, Clinical | Apr 01, 2015 | Sale | $30.86 | 5,000 | 154,300 | 0 | Apr 03, 2015, 07:57 AM |
Wigginton Jon Marc | Sr VP, Clinical | Feb 02, 2015 | Option Exercise | $4.70 | 5,000 | 23,500 | 5,000 | Feb 03, 2015, 02:58 PM |
Wigginton Jon Marc | Sr VP, Clinical | Feb 02, 2015 | Sale | $31.04 | 5,000 | 155,200 | 0 | Feb 03, 2015, 02:58 PM |
Karrels James | VP, CFO and Secretary | Dec 24, 2014 | Option Exercise | $0.94 | 4,100 | 3,854 | 4,100 | Dec 29, 2014, 08:05 AM |
Stein Kathryn E | SVP, Product Dev. & Regulatory | Dec 22, 2014 | Option Exercise | $0.07 | 10,946 | 777 | 54,151 | Dec 23, 2014, 11:55 AM |
Stein Kathryn E | SVP, Product Dev. & Regulatory | Dec 22, 2014 | Sale | $37.00 | 10,946 | 405,002 | 43,205 | Dec 23, 2014, 11:55 AM |
Risser Eric Blasius | VP, Business Development | Dec 22, 2014 | Option Exercise | $19.59 | 10,000 | 195,950 | 5,000 | Dec 23, 2014, 11:33 AM |
Risser Eric Blasius | VP, Business Development | Dec 18, 2014 | Option Exercise | $0.94 | 10,000 | 9,400 | 10,000 | Dec 22, 2014, 11:04 AM |
Risser Eric Blasius | VP, Business Development | Dec 18, 2014 | Sale | $33.50 | 10,000 | 335,000 | 0 | Dec 22, 2014, 11:04 AM |
Stein Kathryn E | SVP, Product Dev. & Regulatory | Dec 18, 2014 | Option Exercise | $0.71 | 10,946 | 7,772 | 54,151 | Dec 22, 2014, 11:02 AM |
Stein Kathryn E | SVP, Product Dev. & Regulatory | Dec 18, 2014 | Sale | $33.00 | 10,946 | 361,218 | 43,205 | Dec 22, 2014, 11:02 AM |
Koenig Scott | President and CEO | Dec 19, 2014 | Option Exercise | $0.94 | 62,205 | 58,473 | 703,414 | Dec 22, 2014, 11:02 AM |
Risser Eric Blasius | VP, Business Development | Nov 24, 2014 | Option Exercise | $0.94 | 10,000 | 9,400 | 10,000 | Nov 25, 2014, 02:12 PM |
Risser Eric Blasius | VP, Business Development | Nov 24, 2014 | Sale | $27.75 | 10,000 | 277,500 | 0 | Nov 25, 2014, 02:12 PM |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | Nov 21, 2014 | Option Exercise | $0.71 | 10,946 | 7,772 | 54,151 | Nov 24, 2014, 04:34 PM |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | Nov 21, 2014 | Sale | $27.00 | 10,946 | 295,542 | 43,205 | Nov 24, 2014, 04:34 PM |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | Nov 17, 2014 | Option Exercise | $0.94 | 2,090 | 1,965 | 45,295 | Nov 17, 2014, 05:11 PM |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | Nov 14, 2014 | Option Exercise | $0.94 | 23,211 | 21,818 | 66,416 | Nov 17, 2014, 05:11 PM |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | Nov 17, 2014 | Sale | $22.95 | 2,090 | 47,966 | 43,205 | Nov 17, 2014, 05:11 PM |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | Nov 14, 2014 | Sale | $23.33 | 23,211 | 541,513 | 43,205 | Nov 17, 2014, 05:11 PM |
Bonvini Ezio | Senior VP, Research | Nov 14, 2014 | Option Exercise | $0.71 | 3,900 | 2,769 | 36,390 | Nov 17, 2014, 05:11 PM |
Risser Eric Blasius | VP, Business Development | Nov 13, 2014 | Option Exercise | $0.94 | 10,000 | 9,400 | 10,000 | Nov 13, 2014, 02:48 PM |
Risser Eric Blasius | VP, Business Development | Nov 12, 2014 | Option Exercise | $0.94 | 10,000 | 9,400 | 15,000 | Nov 13, 2014, 02:48 PM |
Risser Eric Blasius | VP, Business Development | Nov 12, 2014 | Sale | $23.00 | 15,000 | 345,000 | 0 | Nov 13, 2014, 02:48 PM |
Risser Eric Blasius | VP, Business Development | Nov 13, 2014 | Sale | $25.00 | 10,000 | 250,000 | 0 | Nov 13, 2014, 02:48 PM |
SARAN ATUL | See remarks | Oct 28, 2014 | Option Exercise | $21.79 | 865 | 18,848 | 21,635 | Oct 30, 2014, 04:51 PM |
Bonvini Ezio | Senior VP, Research | Oct 10, 2014 | Option Exercise | $0.71 | 400 | 284 | 32,890 | Oct 15, 2014, 01:38 PM |
Bonvini Ezio | Senior VP, Research | Oct 09, 2014 | Option Exercise | $0.71 | 2,663 | 1,891 | 32,490 | Oct 10, 2014, 02:54 PM |
Bonvini Ezio | Senior VP, Research | Oct 08, 2014 | Option Exercise | $0.94 | 1,597 | 1,501 | 29,827 | Oct 10, 2014, 02:54 PM |
Wigginton Jon Marc | Sr V.P., Clinical | Oct 01, 2014 | Option Exercise | $4.70 | 5,000 | 23,500 | 5,000 | Oct 02, 2014, 11:33 AM |
Wigginton Jon Marc | Sr V.P., Clinical | Oct 01, 2014 | Sale | $20.48 | 5,000 | 102,400 | 0 | Oct 02, 2014, 11:33 AM |
Risser Eric Blasius | VP, Business Development | Sep 02, 2014 | Sale | $20.89 | 8,316 | 173,721 | 5,000 | Sep 02, 2014, 04:33 PM |
Wigginton Jon Marc | Senior VP, Clinical Dev. | Aug 18, 2014 | Option Exercise | $4.70 | 5,000 | 23,500 | 5,000 | Aug 19, 2014, 06:43 PM |
Wigginton Jon Marc | Senior VP, Clinical Dev. | Aug 18, 2014 | Sale | $20.52 | 5,000 | 102,600 | 0 | Aug 19, 2014, 06:43 PM |
Risser Eric Blasius | VP, Business Development | Jun 30, 2014 | Option Exercise | $0.94 | 8,000 | 7,520 | 21,316 | Jul 01, 2014, 07:04 PM |
Risser Eric Blasius | VP, Business Development | Jun 30, 2014 | Sale | $21.84 | 8,000 | 174,720 | 13,316 | Jul 01, 2014, 07:04 PM |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | May 29, 2014 | Option Exercise | $0.71 | 10,946 | 7,772 | 54,151 | May 30, 2014, 02:01 PM |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | May 29, 2014 | Sale | $19.75 | 10,946 | 216,184 | 43,205 | May 30, 2014, 02:01 PM |
HURWITZ EDWARD | Director | Feb 18, 2014 | Sale | $36.50 | 308,513 | 11,260,725 | 1,704,996 | Feb 18, 2014, 04:16 PM |
ORONSKY ARNOLD L | Director | Feb 18, 2014 | Sale | $36.50 | 200,000 | 7,300,000 | 1,708,716 | Feb 18, 2014, 04:03 PM |
Galbraith Kenneth | Director | Oct 16, 2013 | Buy | $16.00 | 46,875 | 750,000 | 46,875 | Oct 18, 2013, 02:36 PM |
Owner | Relationship | Date | Value($) |
Peters Jeffrey Stuart | Senior VP and General Counsel | 03/06/2024 | 213,875 |
Peters Jeffrey Stuart | Senior VP and General Counsel | 03/06/2024 | 421,938 |
Risser Eric Blasius | Chief Operating Officer | 03/04/2024 | 152,250 |
Risser Eric Blasius | Chief Operating Officer | 03/04/2024 | 813,501 |
Spitznagel Thomas | Sr VP, Technical Ops | 03/04/2024 | 115,000 |
Spitznagel Thomas | Sr VP, Technical Ops | 03/04/2024 | 200,000 |
Karrels James | SVP, CFO and Secretary | 03/04/2024 | 615,000 |
Peters Jeffrey Stuart | Senior VP and General Counsel | 02/26/2024 | 277,655 |
Peters Jeffrey Stuart | Senior VP and General Counsel | 02/22/2024 | 173,256 |
Bonvini Ezio | Sr VP, Research & CSO | 02/22/2024 | 160,252 |
Eck Stephen L. | Chief Medical Officer | 02/15/2024 | 119,573 |
Peters Jeffrey Stuart | Senior VP and General Counsel | 02/15/2024 | 77,273 |
Koenig Scott | President and CEO | 02/15/2024 | 249,673 |
Cilinski Lynn | VP, Controller and Treasurer | 02/15/2024 | 41,377 |
Risser Eric Blasius | Chief Operating Officer | 02/15/2024 | 102,295 |
Karrels James | SVP, CFO and Secretary | 02/15/2024 | 92,690 |
Spitznagel Thomas | Sr VP, Technical Ops | 02/15/2024 | 87,348 |
Bonvini Ezio | Sr VP, Research & CSO | 02/15/2024 | 102,155 |
Bonvini Ezio | Sr VP, Research & CSO | 02/07/2024 | 60,012 |
Peters Jeffrey Stuart | Senior VP and General Counsel | 02/05/2024 | 847,355 |
Peters Jeffrey Stuart | Senior VP and General Counsel | 02/05/2024 | 1,258,142 |
Bonvini Ezio | Sr VP, Research & CSO | 02/01/2024 | 199,740 |
Bonvini Ezio | Sr VP, Research & CSO | 01/19/2024 | 159,792 |
Bonvini Ezio | Sr VP, Research & CSO | 12/20/2023 | 190,310 |
BIOTECH TARGET N V | 10% Owner | 10/02/2023 | 669,585 |
BIOTECH TARGET N V | 10% Owner | 09/07/2023 | 1,052,840 |
HURWITZ EDWARD | Director | 08/30/2023 | 73,650 |
Peters Jeffrey Stuart | Senior VP and General Counsel | 03/10/2023 | 32,393 |
Peters Jeffrey Stuart | Senior VP and General Counsel | 02/22/2023 | 22,126 |
Bonvini Ezio | Sr VP, Research & CSO | 02/22/2023 | 23,704 |
BIOTECH TARGET N V | 10% Owner | 02/14/2023 | 2,532,600 |
BIOTECH TARGET N V | 10% Owner | 01/19/2023 | 794,925 |
BIOTECH TARGET N V | 10% Owner | 12/27/2022 | 1,121,800 |
BIOTECH TARGET N V | 10% Owner | 12/23/2022 | 1,176,800 |
BIOTECH TARGET N V | 10% Owner | 11/22/2022 | 1,788,180 |
Risser Eric Blasius | Chief Operating Officer | 10/28/2022 | 12,835 |
BIOTECH TARGET N V | 10% Owner | 10/21/2022 | 1,157,100 |
BIOTECH TARGET N V | 10% Owner | 10/24/2022 | 1,090,500 |
BIOTECH TARGET N V | 10% Owner | 10/20/2022 | 1,143,565 |
BIOTECH TARGET N V | 10% Owner | 10/19/2022 | 623,919 |
Karrels James | SVP, CFO and Secretary | 06/15/2022 | 98,800 |
Bonvini Ezio | Sr VP, Research & CSO | 05/14/2022 | 6,931 |
Koenig Scott | President and CEO | 05/16/2022 | 80,430 |
Karrels James | SVP, CFO and Secretary | 03/28/2022 | 12,557 |
Risser Eric Blasius | Chief Operating Officer | 03/04/2022 | 470 |
BIOTECH TARGET N V | 10% Owner | 11/19/2021 | 3,700,320 |
Bonvini Ezio | Sr VP, Research & CSO | 11/16/2021 | 40,640 |
BIOTECH TARGET N V | 10% Owner | 09/29/2021 | 2,047,460 |
BIOTECH TARGET N V | 10% Owner | 09/28/2021 | 2,063,960 |
BIOTECH TARGET N V | 10% Owner | 09/16/2021 | 8,376,800 |
BIOTECH TARGET N V | 10% Owner | 09/17/2021 | 3,986,680 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 07/16/2021 | 37,550 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 07/16/2021 | 125,050 |
Bonvini Ezio | Sr VP, Research & CSO | 06/24/2021 | 436,337 |
BIOTECH TARGET N V | 10% Owner | 06/21/2021 | 1,630,170 |
BIOTECH TARGET N V | 10% Owner | 06/15/2021 | 1,539,615 |
BIOTECH TARGET N V | 10% Owner | 06/16/2021 | 2,104,390 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 04/15/2021 | 37,550 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 04/15/2021 | 154,550 |
Karrels James | SVP, CFO and Secretary | 03/22/2021 | 495,000 |
Bonvini Ezio | Sr VP, Research & CSO | 03/22/2021 | 125,344 |
Peters Jeffrey Stuart | General Counsel | 03/08/2021 | 250,114 |
Peters Jeffrey Stuart | General Counsel | 03/08/2021 | 576,349 |
Karrels James | SVP, CFO and Secretary | 01/28/2021 | 8,490 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 12/29/2020 | 755 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 12/29/2020 | 12,050 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 11/30/2020 | 755 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 11/30/2020 | 11,675 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 10/28/2020 | 2,265 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 10/28/2020 | 31,035 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 09/28/2020 | 755 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 09/28/2020 | 12,665 |
Bonvini Ezio | Sr VP, Research & CSO | 09/18/2020 | 586,848 |
Bonvini Ezio | Sr VP, Research & CSO | 09/17/2020 | 1,330,019 |
Galbraith Kenneth | Director | 09/09/2020 | 361,103 |
Galbraith Kenneth | Director | 09/09/2020 | 563,156 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 08/26/2020 | 755 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 08/26/2020 | 13,550 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 08/20/2020 | 56,325 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 08/20/2020 | 201,525 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 07/27/2020 | 6,500 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 07/27/2020 | 114,319 |
Peters Jeffrey Stuart | General Counsel | 07/02/2020 | 6,060 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 07/02/2020 | 4,681 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 07/02/2020 | 93,000 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 06/24/2020 | 470 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 06/24/2020 | 14,245 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 05/26/2020 | 470 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 05/26/2020 | 13,295 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 05/20/2020 | 56,325 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 05/20/2020 | 189,750 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 05/06/2020 | 11,843 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 05/06/2020 | 168,300 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 04/16/2020 | 5,640 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 03/13/2020 | 5,640 |
Koenig Scott | President and CEO | 03/11/2020 | 125,173 |
Karrels James | SVP, CFO and Secretary | 03/06/2020 | 4,205 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 02/20/2020 | 470 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 02/20/2020 | 5,420 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 02/04/2020 | 28 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 02/05/2020 | 586 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 02/05/2020 | 6,230 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 02/04/2020 | 300 |
Karrels James | SVP, CFO and Secretary | 01/30/2020 | 11,750 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 09/27/2019 | 1,562 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 05/20/2019 | 2,820 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 05/22/2019 | 940 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 05/22/2019 | 19,026 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 05/20/2019 | 55,131 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 03/14/2019 | 2,347 |
Fust Matthew K | Director | 02/06/2019 | 139,519 |
Fust Matthew K | Director | 02/06/2019 | 203,427 |
Peters Jeffrey Stuart | General Counsel | 02/06/2019 | 2,040 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 02/06/2019 | 13,293 |
Spitznagel Thomas | Sr VP, BPD & Manufacturing | 02/06/2019 | 53,100 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 01/28/2019 | 5,640 |
Karrels James | SVP, CFO and Secretary | 01/24/2019 | 6,886 |
Karrels James | SVP, CFO and Secretary | 01/08/2019 | 4,995 |
Koenig Scott | President and CEO | 01/03/2019 | 37,503 |
Karrels James | SVP, CFO and Secretary | 12/18/2018 | 4,700 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 12/12/2018 | 4,700 |
Karrels James | SVP, CFO and Secretary | 11/27/2018 | 2,820 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 11/13/2018 | 3,760 |
Koenig Scott | President and CEO | 11/13/2018 | 37,600 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 10/22/2018 | 2,820 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 03/12/2018 | 940 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 03/12/2018 | 31,080 |
Karrels James | SVP, CFO and Secretary | 03/05/2018 | 155,000 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 03/02/2018 | 3,760 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 03/02/2018 | 120,000 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 02/28/2018 | 940 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 02/28/2018 | 25,005 |
Cilinski Lynn | VP, Controller and Treasurer | 02/28/2018 | 27,083 |
Cilinski Lynn | VP, Controller and Treasurer | 02/28/2018 | 599,436 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 02/26/2018 | 259,702 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 01/24/2018 | 2,820 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 01/24/2018 | 67,500 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 01/24/2018 | 2,820 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 01/24/2018 | 67,500 |
Karrels James | SVP, CFO and Secretary | 01/16/2018 | 6,125 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 01/17/2018 | 11,863 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 01/16/2018 | 11,637 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 01/17/2018 | 50,480 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 01/16/2018 | 49,520 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 01/17/2018 | 1,880 |
Karrels James | SVP, CFO and Secretary | 12/29/2017 | 2,820 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 11/21/2017 | 23,500 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 11/21/2017 | 100,000 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 10/25/2017 | 47,000 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 10/25/2017 | 200,000 |
Karrels James | SVP, CFO and Secretary | 09/05/2017 | 4,700 |
Risser Eric Blasius | Sr VP & Chief Business Officer | 09/05/2017 | 1,880 |
Bonvini Ezio | Sr VP, Research & CSO | 07/26/2017 | 65,248 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 06/05/2017 | 23,500 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 06/05/2017 | 100,000 |
SARAN ATUL | SVP & General Counsel | 04/28/2017 | 40,238 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 04/19/2017 | 70,500 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 04/19/2017 | 300,000 |
Karrels James | SVP, CFO and Secretary | 01/25/2017 | 4,700 |
Koenig Scott | President and CEO | 01/17/2017 | 75,104 |
Bonvini Ezio | Sr VP, Research & CSO | 10/19/2016 | 5,028 |
Bonvini Ezio | Sr VP, Research & CSO | 02/11/2016 | 11,244 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 10/03/2016 | 47,000 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 10/03/2016 | 293,400 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 10/03/2016 | 47,000 |
Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 10/03/2016 | 293,400 |
Cilinski Lynn | VP, Controller and Treasurer | 10/03/2016 | 5,857 |
Cilinski Lynn | VP, Controller and Treasurer | 10/03/2016 | 182,444 |
Wigginton Jon Marc | Sr VP Clinical Dev & CMO | 08/01/2016 | 94,000 |
Wigginton Jon Marc | Sr VP Clinical Dev & CMO | 08/01/2016 | 615,600 |
Wigginton Jon Marc | Sr VP Clinical Dev & CMO | 07/01/2016 | 23,500 |
Wigginton Jon Marc | Sr VP Clinical Dev & CMO | 07/01/2016 | 136,100 |
Cilinski Lynn | VP, Controller and Treasurer | 07/01/2016 | 8,387 |
Cilinski Lynn | VP, Controller and Treasurer | 07/01/2016 | 242,857 |
SARAN ATUL | SVP & General Counsel | 04/28/2016 | 38,804 |
Cilinski Lynn | VP, Controller and Treasurer | 05/27/2016 | 4,700 |
Cilinski Lynn | VP, Controller and Treasurer | 05/27/2016 | 125,000 |
Koenig Scott | President and CEO | 05/16/2016 | 32,542 |
Koenig Scott | President and CEO | 05/11/2016 | 75,104 |
SARAN ATUL | SVP & General Counsel | 04/28/2016 | 36,053 |
Costa Paulo F | Director | 03/03/2016 | 172,000 |
Risser Eric Blasius | SVP, Business Development | 02/08/2016 | 2,350 |
Karrels James | SVP, CFO and Secretary | 01/29/2016 | 9,400 |
Stein Kathryn E | SVP, Product Dev. & Regulatory | 01/07/2016 | 44,825 |
Bonvini Ezio | Senior VP, Research | 01/07/2016 | 12,517 |
Wigginton Jon Marc | Sr VP, Clinical | 01/04/2016 | 47,000 |
Wigginton Jon Marc | Sr VP, Clinical | 01/04/2016 | 296,400 |
Risser Eric Blasius | SVP, Business Development | 12/23/2015 | 1,410 |
Cilinski Lynn | VP, Controller and Treasurer | 07/01/2015 | 3,586 |
Cilinski Lynn | VP, Controller and Treasurer | 11/23/2015 | 1,114 |
Cilinski Lynn | VP, Controller and Treasurer | 11/23/2015 | 242,235 |
Bonvini Ezio | Senior VP, Research | 11/16/2015 | 97,998 |
Bonvini Ezio | Senior VP, Research | 10/15/2015 | 157,134 |
Bonvini Ezio | Senior VP, Research | 10/13/2015 | 381,031 |
Karrels James | SVP, CFO and Secretary | 10/07/2015 | 5,640 |
Wigginton Jon Marc | Sr VP, Clinical | 10/01/2015 | 23,500 |
Wigginton Jon Marc | Sr VP, Clinical | 10/01/2015 | 105,550 |
Wigginton Jon Marc | Sr VP, Clinical | 08/03/2015 | 47,000 |
Wigginton Jon Marc | Sr VP, Clinical | 08/03/2015 | 371,500 |
Bonvini Ezio | Senior VP, Research | 10/02/2015 | 16,804 |
Wigginton Jon Marc | Sr VP, Clinical | 10/01/2015 | 23,500 |
Wigginton Jon Marc | Sr VP, Clinical | 10/01/2015 | 105,550 |
Bonvini Ezio | Senior VP, Research | 09/18/2015 | 6,580 |
Bonvini Ezio | Senior VP, Research | 09/16/2015 | 3,760 |
Bonvini Ezio | Senior VP, Research | 08/27/2015 | 4,700 |
Bonvini Ezio | Senior VP, Research | 08/26/2015 | 4,700 |
Bonvini Ezio | Senior VP, Research | 08/10/2015 | 75,200 |
Wigginton Jon Marc | Sr VP, Clinical | 08/03/2015 | 47,000 |
Wigginton Jon Marc | Sr VP, Clinical | 08/03/2015 | 371,500 |
Bonvini Ezio | Senior VP, Research | 07/10/2015 | 1,704 |
Bonvini Ezio | Senior VP, Research | 07/10/2015 | 91,416 |
Cilinski Lynn | VP, Controller and Treasurer | 07/01/2015 | 4,700 |
Cilinski Lynn | VP, Controller and Treasurer | 07/01/2015 | 257,115 |
Wigginton Jon Marc | Sr VP, Clinical | 07/01/2015 | 23,500 |
Wigginton Jon Marc | Sr VP, Clinical | 07/01/2015 | 185,750 |
Bonvini Ezio | Senior VP, Research | 06/30/2015 | 4,613 |
Bonvini Ezio | Senior VP, Research | 06/30/2015 | 247,341 |
Bonvini Ezio | Senior VP, Research | 06/24/2015 | 4,329 |
Bonvini Ezio | Senior VP, Research | 06/24/2015 | 232,174 |
Bonvini Ezio | Senior VP, Research | 06/23/2015 | 9,268 |
Bonvini Ezio | Senior VP, Research | 06/23/2015 | 497,880 |
Bonvini Ezio | Senior VP, Research | 06/24/2015 | 232,174 |
Bonvini Ezio | Senior VP, Research | 06/23/2015 | 497,880 |
Cilinski Lynn | VP, Controller and Treasurer | 06/15/2015 | 4,700 |
Cilinski Lynn | VP, Controller and Treasurer | 06/15/2015 | 374,500 |
Bonvini Ezio | Senior VP, Research | 06/15/2015 | 4,425 |
Bonvini Ezio | Senior VP, Research | 06/15/2015 | 211,984 |
Bonvini Ezio | Senior VP, Research | 05/15/2015 | 4,425 |
Bonvini Ezio | Senior VP, Research | 05/15/2015 | 188,486 |
SARAN ATUL | General Counsel | 04/28/2015 | 29,619 |
Bonvini Ezio | Senior VP, Research | 04/15/2015 | 4,425 |
Bonvini Ezio | Senior VP, Research | 04/15/2015 | 211,797 |
Wigginton Jon Marc | Sr VP, Clinical | 04/01/2014 | 23,500 |
Wigginton Jon Marc | Sr VP, Clinical | 04/01/2015 | 154,300 |
Wigginton Jon Marc | Sr VP, Clinical | 02/02/2015 | 23,500 |
Wigginton Jon Marc | Sr VP, Clinical | 02/02/2015 | 155,200 |
Karrels James | VP, CFO and Secretary | 12/24/2014 | 3,854 |
Stein Kathryn E | SVP, Product Dev. & Regulatory | 12/22/2014 | 777 |
Stein Kathryn E | SVP, Product Dev. & Regulatory | 12/22/2014 | 405,002 |
Risser Eric Blasius | VP, Business Development | 12/22/2014 | 195,950 |
Risser Eric Blasius | VP, Business Development | 12/18/2014 | 9,400 |
Risser Eric Blasius | VP, Business Development | 12/18/2014 | 335,000 |
Stein Kathryn E | SVP, Product Dev. & Regulatory | 12/18/2014 | 7,772 |
Stein Kathryn E | SVP, Product Dev. & Regulatory | 12/18/2014 | 361,218 |
Koenig Scott | President and CEO | 12/19/2014 | 58,473 |
Risser Eric Blasius | VP, Business Development | 11/24/2014 | 9,400 |
Risser Eric Blasius | VP, Business Development | 11/24/2014 | 277,500 |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 11/21/2014 | 7,772 |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 11/21/2014 | 295,542 |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 11/17/2014 | 1,965 |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 11/14/2014 | 21,818 |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 11/17/2014 | 47,966 |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 11/14/2014 | 541,513 |
Bonvini Ezio | Senior VP, Research | 11/14/2014 | 2,769 |
Risser Eric Blasius | VP, Business Development | 11/13/2014 | 9,400 |
Risser Eric Blasius | VP, Business Development | 11/12/2014 | 9,400 |
Risser Eric Blasius | VP, Business Development | 11/12/2014 | 345,000 |
Risser Eric Blasius | VP, Business Development | 11/13/2014 | 250,000 |
SARAN ATUL | See remarks | 10/28/2014 | 18,848 |
Bonvini Ezio | Senior VP, Research | 10/10/2014 | 284 |
Bonvini Ezio | Senior VP, Research | 10/09/2014 | 1,891 |
Bonvini Ezio | Senior VP, Research | 10/08/2014 | 1,501 |
Wigginton Jon Marc | Sr V.P., Clinical | 10/01/2014 | 23,500 |
Wigginton Jon Marc | Sr V.P., Clinical | 10/01/2014 | 102,400 |
Risser Eric Blasius | VP, Business Development | 09/02/2014 | 173,721 |
Wigginton Jon Marc | Senior VP, Clinical Dev. | 08/18/2014 | 23,500 |
Wigginton Jon Marc | Senior VP, Clinical Dev. | 08/18/2014 | 102,600 |
Risser Eric Blasius | VP, Business Development | 06/30/2014 | 7,520 |
Risser Eric Blasius | VP, Business Development | 06/30/2014 | 174,720 |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 05/29/2014 | 7,772 |
Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 05/29/2014 | 216,184 |
HURWITZ EDWARD | Director | 02/18/2014 | 11,260,725 |
ORONSKY ARNOLD L | Director | 02/18/2014 | 7,300,000 |
Galbraith Kenneth | Director | 10/16/2013 | 750,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 6,140,349 | 0.00151% | 1.73% | Other |
RA CAPITAL MANAGEMENT, L.P. | 4,053,077 | 0.61% | 1085.11% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,404,068 | 0.00141% | 6.37% | Other |
RENAISSANCE TECHNOLOGIES LLC | 763,527 | 0.01% | 14.79% | Other |
AQR CAPITAL MANAGEMENT LLC | 132,374 | 0.0024% | -61.14% | Other |
TUDOR INVESTMENT CORP ET AL | 139,080 | 0.0065% | Exited | Event Driven, Other |
ALPS ADVISORS INC | 41,674 | 0.00315% | -8.8% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 38,947 | 0.0007% | 246.13% | Event Driven |
Period of Report: 12/31/2023
10-K/10-Q Filings: View